Sally Davis joined the National Brain Tumor Society as its Chief Executive Officer in 2014. In this role, she will lead the Organization’s operations to achieve its strategic goals through targeted research programs, key public policy initiatives, and financial growth. Prior to joining the National Brain Tumor Society, she was the National Vice President, Development and Foundations for the Boys & Girls Clubs of America. Ms. Davis has more than 20 years of professional experience across both the public and private sector in academia, insurance, and the pharmaceutical industry. She is also the recipient of the Womenetics POW Award, and the WNBA’s ATL Dream Inspiring Women Award. Ms. Davis holds a Bachelor’s and Master’s from Drake University.
Chief Financial Officer
James Charnley is the Chief Financial Officer of the National Brain Tumor Society. He joined the Organization in 2012, and effectively manages the accounting, financial planning, information systems, and human resource operations. He has managed the finance and operations for several social justice, commercial, and financial organizations including Benevolent Fraternity of Unitarian Churches and SCM Community Transportation.
Chief Technology Officer
Mike Sachleben is the Chief Technology Officer of the National Brain Tumor Society. In this role, he oversees all of the online fundraising and engagement platforms, internal infrastructure, analytics, and reports. Mr. Sachleben joined the Organization in 2013. He has been responsible for leading technology teams and re-architecting database platforms, most recently at JustGiving, the UK’s #1 online fundraising website. Prior to working in the online fundraising space, he founded and led a number of companies, including a consulting firm focusing on designing & building databases, database driven applications, and reports.
Chief Research Officer
Carrie Treadwell joined the Organization in 1998 and serves as the Senior Director of Research at the National Brain Tumor Society, as well as Managing Director of the Defeat GBM Research Collaborative, a subsidiary of the Organization. In these roles, she interacts with leading researchers and institutinobs to guide the development and success of key research initiatives including overseeing the Organization’s grant process. She also serves as a patient advocate for the National Cancer Institute’s Brain Tumor SPORE Program.
David F. Arons, JD
Chief Public Policy and Advocacy Officer
David Arons is the Senior Director of Public Policy of the National Brain Tumor Society. In this role, he directs the Organization’s federal and state public policy efforts and nationwide advocacy program. He previously served as the Director of Government Relations for the American Cancer Society. He is the author of several books, including Power in Policy: A Funder’s Guide to Advocacy and Civic Participation, Strengthening Nonprofit Advocacy, and A Voice for Nonprofits and serves on the National Cancer Institute, NIH Director’s Consumer Liaison Group.
Chief Marketing & Community Relations Officer
Kristina Knight is the Chief Marketing and Community Relations Officer of the National Brain Tumor Society. In this role, she is responsible for directing the community engagement strategies with other organizations and key individuals, and oversees the brand experience and tone of the organization. Ms. Knight joined the Brain Tumor Society in 2007, which then merged with the National Brain Tumor Foundation to become the National Brain Tumor Society in 2008. Prior to working in the brain tumor community, she was responsible for in-house marketing departments in various industries, and worked in business development for several branding agencies.
Alison Bengel, MBA
Director of Marketing Communications
Alison Bengel is the Director of Marketing Communications for the National Brain Tumor Society. Ms. Bengel joined the Organization in 2012, and leads the external communication strategies and campaigns including all public relations, brand management, events marketing, and message development. Her industry knowledge and experience also includes high technology, managed care, and most recently life sciences. Ms. Bengel is active with community-based organizations such as Sustainable Watertown and serves on the JP@Home advisory board.
Michael Nathanson is the Chair of the National Brain Tumor Society Board of Directors. He is also the Chief Executive Officer, President, and Chairman of The Colony Group, a leading independent wealth management company. He has been on the National Brain Tumor Society’s Board of Directors since 2011. He has been named five times by Barrons as one of the top 100 independent financial advisors in the nation. Mr. Nathanson has been living with a brain tumor since 2000.
Cord Schlobohm, DMD
Cord Schlobohm, DMD is the Vice Chair of the National Brain Tumor Society Board of Directors. He has been a practicing dentist in Bethesda, MD for over 25 years. Dr. Schlobohm became involved with the National Brain Tumor Society after losing his daughter to a brain tumor. He recently served as a patient advocate on the peer-reviewed Cancer Research Program of the Department of Defense, and has spoken on NPR on behalf of the National Brain Tumor Society.
Michael Corkin is the Treasurer of the National Brain Tumor Society Board of Directors. He is also the President and Owner of Corkin Insurance Company, based in Newton, Massachusetts. He initially became involved with the Organization after his daughter was diagnosed and successfully operated on for a brain tumor 20 years ago. He is also a leading fundraiser for the Boston Brain Tumor Ride and in recent years served as the event co-chair.
Sarah Durham is the Clerk of the National Brain Tumor Society Board of Directors. She is the Principal and Founder of Big Duck, a communications firm that works exclusively with nonprofits to help reach supporters, build awareness, and raise money. She was named a top fundraiser under 40 by Fundraising Success in 2006, and one of the most influential women in technology by Fast Company in 2010.